Sort
10,766 grants matching “checkpoint inhibitor”
Development of Sapacitabine Therapy in Leukemias
$237,113William K Plunkett · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA
Identifying novel resistance mechanisms in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG)
$237,023John Sfakianos · Icahn School Of Medicine At Mount Sinai · R21 · FY2023 · CA
Targeting the Androgen Receptor to Sensitize Bladder Cancer to Immune Check Point Blockade.
$237,023David Mulholland · Icahn School Of Medicine At Mount Sinai · R21 · FY2024 · CA
Development of Molecular Microbubble Probes and Ultrasound-Guidance in Immunotherapeutic Strategies
$236,985Ahmed El Kaffas · Stanford University · R21 · FY2021 · EB
HDAC4 Viability: Unique Mechanisms and Function
$236,702Gary D Kao · University Of Pennsylvania · R01 · FY2007 · CA
Molecular Imaging Reagents for Prostate Cancer Theranostics
$236,471Zaver M Bhujwalla · Johns Hopkins University · P41 · FY2021 · EB
P3: Molecular Mechanisms Underlying Therapy Response to Radiation and Immune Checkpoint BlockadeýSUBAWARD
$236,408David Sung-Wen Yu · Cleveland Clinic Lerner Com-Cwru · U54 · FY2022 · CA
Project 1: Combining PARP inhibition with radiation to sensitize HR proficient pancreatic cancers to immunotherapy
$236,326Meredith A Morgan · University Of Michigan At Ann Arbor · P50 · FY2025 · CA
Developing GRB2-PROTACs for Treatment of Lung Cancer
$236,321Haitao Mark Ji · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2023 · CA
Defining and targeting the immune-suppressive metabolic microenvironment of leptomeningeal melanoma metastases
$236,321Inna Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2022 · CA
Prediction and Treatment for Cancer Immunotherapy Induced Myocarditis
$236,250Hua Pan · Washington University · R21 · FY2022 · HL
MOLECULAR MECHANISMS OF MAMMALIAN CHECKPOINT PATHWAYS
$236,250St. Jude Children'S Research Hospital · R01 · FY2004 · CA
Multifunctional Nanoprobe for Early Appraisal of Immunotherapeutic Efficacy
$236,250Srikanth Singamaneni · Washington University · R21 · FY2021 · EB
ASPECTS OF UTERINE CELL CYCLE REGULATION IN IMPLANTATION
$236,250University Of Kansas Medical Center · R01 · FY2001 · HD
MOLECULAR MECHANISMS OF MAMMALIAN CHECKPOINT PATHWAYS
$236,250St. Jude Children'S Research Hospital · R01 · FY2003 · CA
Single-Cell Transcriptome & Effect of Immune Checkpoint Therapy on Kaposi Sarcoma
$236,250Lee Ratner · Washington University · R21 · FY2022 · CA
MOLECULAR MECHANISMS OF MAMMALIAN CHECKPOINT PATHWAYS
$235,988St. Jude Children'S Research Hospital · R01 · FY2002 · CA
Chemical platform to produce covalent biologics
$235,901Alexander V Statsyuk · University Of Houston · R21 · FY2022 · GM
Immune cell states in endocrine immune related adverse events (IRAEs)
$235,895Melissa G Lechner · University Of California Los Angeles · U19 · FY2025 · AI
RP-3: Elucidating Mechanisms of Sensitivity and Resistance to Checkpoint Blockade Therapy for Rational Multi-Drug Immunotherapy in Urothelial Cancers
$235,745Jonathan Eric Rosenberg · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
P53 MEDIATED G2/M CHECKPOINT CONTROL
$235,675Thomas Jefferson University · R01 · FY2000 · CA
Specificity of the Ubiquitin System in Lymphoid Malignancies
$235,667Luca Busino · University Of Pennsylvania · R00 · FY2016 · CA
Novel mouse models using MADR-GESTALT technology to accelerate glioma research
$235,632Linda M Liau · University Of California Los Angeles · P50 · FY2023 · CA
Endocrine tissue molecular pathways dysregulated by immune checkpoint inhibitors causing ICI-triggered adverse events
$235,620Yaron Tomer · Albert Einstein College Of Medicine · R21 · FY2023 · CA
PI3K opposes p27 and G1 arrest by TGF-B in human cancer
$235,586Joyce Marie Slingerland · University Of Miami School Of Medicine · R01 · FY2007 · CA